Top Markets
#1 DogBull DogBull +54.86%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +31.07%
#3 OriginTrail OriginTrail +16.39%
#4 MarsCoin MarsCoin +12.31%
#5 DigiByte DigiByte +11.26%
#6 Siren Siren +11.04%
#7 龙虾 (Lobster) 龙虾 (Lobster) +10.68%
#8 Ether.fi Ether.fi +10.50%
#9 Cysic Cysic +10.32%
#10 Ethena Staked ENA Ethena Staked ENA +10.03%
Coin of the day
DogBull DogBull
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Hisse Senetlerindeki Sıralama #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Hisse Fiyatı
$2.23
Son senkronizasyon: 2026-08-21
Piyasa Değeri
$95.23M
Değişim (1 gün)
1.14%
Değişim (1 yıl)
63.60%
Ülke
US
Ticaret Acrivon Therapeutics, Inc. Common Stock (ACRV)

Kategori

Healthcare
Acrivon Therapeutics, Inc. Common Stock (ACRV) için temettü verimi geçmişi
Acrivon Therapeutics, Inc. Common Stock (hisse sembolü: ACRV) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Acrivon Therapeutics, Inc. Common Stock (ACRV) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)
Şirket Temettü Verimi Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH